Form 4: PRO DEX Director Receives Restricted Stock Grant

PRO DEX Director Katrina Marie Kramer Philp was granted 1,000 restricted shares of common stock under the company's 2016 Equity Incentive Plan.

Summary

• Katrina Marie Kramer Philp, a Director of PRO DEX INC (PDEX), acquired 1,000 shares of common stock on November 20, 2025.
• The acquisition was a grant of restricted shares under the Issuer's 2016 Equity Incentive Plan, with a transaction price of $0.00 per share.
• The granted shares will vest in equal installments over five years, contingent on Ms. Philp's continued service to Pro-Dex, Inc.
• Following this transaction, Ms. Philp directly owns 2,000 shares and indirectly owns 14,696 shares through her spouse.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is a positive sign of long-term commitment and aligns interests, though it's a routine compensation event rather than a major operational announcement.

Positives

• The grant of restricted shares aligns the director's interests with long-term shareholder value through a vesting schedule tied to continued service.
• The equity incentive plan encourages the retention of key personnel within the company.

Risks

• The value of the granted shares is subject to market fluctuations of PRO DEX INC common stock.
• Vesting is contingent on continued service, meaning the shares could be forfeited if the director's service ends prematurely.

Future Outlook

The shares vest over five years, indicating a long-term incentive structure designed to encourage the director's continued service to the company.

Industry Context

This transaction represents a standard practice for compensating directors and executives, aiming to align their interests with the company's long-term performance and shareholder value. Such equity grants are common across various sectors.

Comparison to Industry Standards

• Granting restricted stock to directors is a common compensation practice across various industries, including the medical device manufacturing sector where Pro-Dex operates.
• A five-year vesting schedule is a typical long-term incentive structure, comparable to practices seen in companies like Stryker (SYK) or Medtronic (MDT) for their executive and director compensation plans, though specific terms vary.
• The $0.00 price for a grant of restricted stock is standard as it represents an award, not a purchase.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the director's interests with long-term company performance.
• Employees: No direct impact on general employees from this specific filing.

Next Steps

• The granted shares will vest in equal installments over the next five years, subject to the director's continued service.

Key Dates

Recommendation

This Form 4 filing details a routine restricted stock grant to a director as part of their compensation package. While it indicates continued alignment of management interests with long-term shareholder value, it does not present new information that would fundamentally alter the investment thesis for PRO DEX. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals rather than this specific insider transaction.

Keywords

PRO DEX, PDEX, Form 4, Insider Transaction, Restricted Stock, Equity Incentive Plan, Director Compensation, Stock Grant